Objective Previous studies have revealed functional changes within the cerebral hemispheres of patients with SLE; however the ...

Courtesy Getty Images Maternal antibodies can cross the placenta at any time following alloimmunization, but it occurs mostly ...

AnaptysBio’s drug candidates rosnilimab and ANB032 hold key trial results ahead. Find out why ANAB stock is impacted by ...

Zanidatamab is the first agent approved specifically for advanced, HER2-positive second-line biliary tract cancer.

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

As part of an international collaboration, Fred Hutch scientists provided structural information that helped reveal how two ...

We’re about six weeks out from when acute respiratory illness-related hospitalizations peaked in Illinois last year.

An out-of-state law school project noted that much has changed in the 20-plus years since the HIV criminalization laws were ...

Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in 2026 - - VY1706 ...

The agreement gives Pharmanovia the exclusive rights to bring to market, catumaxomab, a first-in-class, trifunctional bi-specific monoclonal antibody, indicated for the intraperitoneal treatment of ...

In the run-up to World AIDS Day Steven Haberman, Professor of Actuarial Science at Bayes Business School, City St George's University of London Steven Haberman made in the 1980s to assessing the ...

Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9% shares of common stock of Aclaris Therapeutics ...